Calorigenic Effects on Growth Hormone: The Role of Thyroid Hormones
GH administration increases energy expenditure, independent of changes in lean body mass, in healthy, obese, and GH-deficient subjects. This may be casually link to the well known GH-induced increase in peripheral T4 to T3 generation, but experimental data are sparse. In this study we have addressed whether 1) the calorigenic effects of GH administration could be reproduced by oral supplementation of T3 in a dose selected to mimic the GH-induced increase in peripheral T3 levels; and 2) combined GH and T3 administration have a synergistic effect on resting energy expenditure (REE).
Eight normal male subjects (aged 21-27 yr; body mass index, 21.11-27.17 kg/m2 ) were randomly studied during four 10-day treatment periods with 1) daily sc placebo injections and placebo tablets, 2) daily sc GH injections (0.1 IU/kgday) and placebo tablets, 3) daily T3 administration (40 mug on even dates, 20 mug on uneven dates) plus placebo injections, and 4) daily GH injections plus T3 administration. GH administration increased both free T3 (F T3 ) levels [mean SE, 6.2 0.3 (control) vs 7.3 0.5 (GH) pmol/L; P<0.05] and REE (resting energy expenditure) [mean d SE, 1959 67 (control) vs 2164 55 (GH_ Cal/24 h; P<0.01]. T3 administration yielded comparable levels of F T3 (7.7 0.5 pmol/L; T3 vs GH, P=0.37), but did not increase REE (2015 48 Cal/24 h; T3 vs control, P=0.23). Combined GH and T3 administration increased REE to a level higher than that seen with T3 alone (2279 68 Cal/24 h; T3 vs GH plus T3 , P
The Journal of Clinical Endocrinology and Metabolism
T. W., T. G., N.M., J. S. C, J. W., J. O. L. J April 1, 1996, Vol. 8, No. 4